GRAIL Reports Third Quarter 2026 Financial Results
GRAIL Inc GRAL
News
GRAIL to Present at the UBS Global Healthcare Conference
7 healthcare stocks that stand out as investors pay up for the sector
7 healthcare stocks that stand out as -2-
GRAIL to Announce Third Quarter 2026 Financial Results
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026
Grail Shares Gain as FDA Panel Votes to Support Cancer Detection Test
Grail's Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval
FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Test
This test screens for 50 cancers - but whether Medicare and other health insurers will cover it hinges on FDA approval
Grail Trading Halted Ahead of FDA AdCom Meeting on Galleri Blood Test
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference
This once-hot cancer-detection company's stock got cut in half after a failed trial
Grail Stock Rises With Funding From Samsung to Bring Cancer Detection Test to Asia
United States